scholarly journals Influence of hyperbaric oxygenation and its use in urinary tract diseases

2016 ◽  
Vol 56 (3) ◽  
pp. 25-32
Author(s):  
Małgorzata Skiba ◽  
Agnieszka Pedrycz

Abstract In this publication, we adduce examples of the use of hyperbaric oxygen therapy in urinary tract diseases. Hyperbaric oxygen therapy has been proved to have a positive influence on the kidneys of animals with diabetes, sepsis or undergoing chemotherapy. In the literature, we can also find many examples of the use of hyperbaric therapy with good clinical outcomes in human patients with prostatic hypertrophy, pyelonephritis, and hemorrhagic cystitis. The first trials of this kind of treatment of urinary tract diseases were started at the end of the twentieth century. In spite of the promising results, and numerous reports on the effectiveness of this non-invasive method of treatment, it is not currently used on a regular basis. Because many factors such as time, multiple applications, the parameters used in the hyperbaric chamber as well as the medications taken by the patient affect the quality of the result, further studies are needed to make hyperbaric therapy more suitable and safer for each patient.

2020 ◽  
pp. 561-569
Author(s):  
Angeliki Chandrinou ◽  
◽  
Anna Korompeli ◽  
Eirini Grammatopoulou ◽  
Konstantina Gaitanou ◽  
...  

Introduction: The treatment of avascular necrosis of the femoral head (AVNFH) is based on invasive (e.g., core decompression) and non-invasive methods (e.g., hyperbaric oxygen therapy – HBO2). The purpose of the present study is to evaluate the effect of HBO2 on the quality of life (QoL) of patients with AVNFH. Methods: This was a prospective observational non-controlled study of patients with AVNFH treated by HBO2. It was conducted, with the use of Steinberg scale, on 73 patients with AVNFH Stage I or II who were treated with HBO2. Patients’ QoL was assessed with EuroQol-5D-5L (EQ), Harris Hip Score (mHHS), MAHORN (MHOT), and VAS, in three different phases: before HBO2; after the completion of the first phase (20 HBO2 sessions, up to two months); and after the completion of the second phase (20 HBO2 sessions, up to two months after the first phase). A reassessment was made on the completion of each phase. Ratings were also made after the completion of each phase, over the first five months of follow-up. Results: All 73 patients (67.1% males, 32.9% females, mean age: 40.34, SD ± 9.99) participated in the study. Steinberg scale, mean EQ (F (1, 57) = 25.18, η2 = .306 and F (1, 43) = 43.402, η2 = .502); mHHS (F (1, 61) = 67.13, η2 = .524) and F (1, 43) = 31.84, η2 = .425); MHOT (F (1, 61) = 11.68, η2 = .161) and F (1, 43) = 98.01, η2 = .695); and VAS (F (1, 53) = 24.11, η2 = .313) and F (1, 39) = 45.61, η2 = .539), improved between the first and second measurements and between the second and third measurement accordingly (p < .01). Conclusions: HBO2 treatment does not induce alteration of quality of life and is well tolerated and accepted by patients.


2015 ◽  
Vol 22 (10) ◽  
pp. 962-966 ◽  
Author(s):  
Tiago M Ribeiro de Oliveira ◽  
António J Carmelo Romão ◽  
Francisco M Gamito Guerreiro ◽  
Tomé M Matos Lopes

2019 ◽  
Vol 18 (11) ◽  
pp. e3507
Author(s):  
H. Takeda ◽  
G. Kimura ◽  
J. Akatsuka ◽  
Y. Endo ◽  
T. Hayashi ◽  
...  

2009 ◽  
Vol 33 (4) ◽  
pp. 556-560 ◽  
Author(s):  
Daniele Focosi ◽  
Fabrizio Maggi ◽  
Donatella Pistolesi ◽  
Edoardo Benedetti ◽  
Federico Papineschi ◽  
...  

2009 ◽  
Vol 75 (3) ◽  
pp. S518-S519
Author(s):  
M. Wong ◽  
L. Daugherty ◽  
B. Fisher ◽  
U. Babaria ◽  
L. Komarnicky

2008 ◽  
Vol 15 (7) ◽  
pp. 639-641 ◽  
Author(s):  
Takahiro Yoshida ◽  
Atsunari Kawashima ◽  
Takeshi Ujike ◽  
Motohide Uemura ◽  
Kensaku Nishimura ◽  
...  

1999 ◽  
Vol 161 (5) ◽  
pp. 1596-1597 ◽  
Author(s):  
PETER D. FURNESS ◽  
LANE S. PALMER ◽  
JEFFREY S. PALMER ◽  
MARY CAPELLI-SCHELLPFEFFER ◽  
EARL Y. CHENG

2021 ◽  
pp. 148-158
Author(s):  
Kübra Özgök Kangal ◽  
Kübra Canarslan Demir

Objective: Radiation-induced hemorrhagic cystitis (RHC) is an accepted hyperbaric oxygen therapy (HBOT) indication. We aimed to analyze the knowledge and the opinions of urology physicians on HBOT in RHS patients with a survey. Materials and Methods: The questionnaires were conducted face to face or online on urology physicians. Results: Seventy-seven urology physicians participated in our study. Physicians have been working for 11 ± 10.5 years in the field of Urology. The 84.4% of our physicians had an average of 0-10 RHC patient administration in a year. However, the majority of the participants stated that they have never referred RHC patients to HBOT. Similarly, 48.1% of the physicians stated that they have insufficient knowledge of HBOT for their specialty. On the other hand, the majority were not sure about the HBOT as an effective treatment option in RHC patients (54.5%), about the cost-effectiveness of HBOT for RHC (66.2%), and the ability of HBOT on shortening the recovery period of RHC patients (49.9%). We observed that physicians who did not have any knowledge on HBOT had statistically significantly lower RHC patient referral rates to HBOT and had more negative opinions on the effectiveness of HBOT in RHC patients (respectively p<0.001, p=0.002). Likewise, physicians who had RHC patient admissions had statistically significantly more positive opinions about HBOT in terms of treatment efficiency, shortening the recovery period, and being a safe treatment option in RHC patients compared to the physicians who did not have any RHC patient admissions (respectively p<0.001, p<0,001, p<0.001). Conclusion: We found that the urology physicians’ knowledge of HBOT application in RHC patients was insufficient. Thus, we realized that they were doubtful about HBOT as an effective RHC treatment option. Likewise, we found out that most of the urology physicians do not refer RHC patients for HBOT. Keywords: hyperbaric oxygen therapy, cystitis, radiation injuries, bladder, urologists


1999 ◽  
pp. 435-437 ◽  
Author(s):  
RANJIV MATHEWS ◽  
NATARAJAN RAJAN ◽  
LAURA JOSEFSON ◽  
ENRICO CAMPORESI ◽  
ZAHI MAKHULI

1999 ◽  
Vol 161 (2) ◽  
pp. 435-437 ◽  
Author(s):  
RANJIV MATHEWS ◽  
NATARAJAN RAJAN ◽  
LAURA JOSEFSON ◽  
ENRICO CAMPORESI ◽  
ZAHI MAKHULI

Sign in / Sign up

Export Citation Format

Share Document